By adjusting the levels of a key signaling protein, researchers from The Children’s Hospital of Philadelphia (CHOP) improved motor function and brain abnormalities in experimental animals with a form of Huntington’s disease, a severe neurodegenerative disorder. The new findings are expected to lay the groundwork of a novel treatment for people with this fatal, progressive disease. The opensource study is![]()
